東北大学加齢医学研究所　臨床腫瘍学分野　東北大学　腫瘍内科

研究室紹介

HOME < 研究業績 < 英文論文 2021年度

英文論文 2021年度

  1. Takahashi S，Sakamoto Y，Denda T，Takashima A，Komatsu Y，Nakamura M，Ohori H，Yamaguchi T，Kobayashi Y，Baba H，Kotake M，Amagai K，Kondo H，Shimada K，Sato A，Yuki S，Okita A，Ouchi K，Komine K，Watanabe M，Morita S，Ishioka C. Advanced colorectal cancer subtypes (aCRCS) help select oxaliplatin-based or irinotecan-based therapy for colorectal cancer. Cancer Science 112. 1567-1578. Apr (2021)
  2. Yamada H，Takahashi M，Watanuki M，Watanabe M，Hiraide S，Saijo K，Komine K，Ishioka C. lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma. Oncology Letters 21. Apr 8 (2021)
  3. Takahashi M，Sakamoto Y，Otsuka K，Kanbe M，Ohori H，Shindo Y，Honda H，Saijo K，Ouchi K，Murakawa Y，Takahashi H，Kawai S，Tanaka Y，Yamaguchi T，Shimodaira H，Yoshioka T，Ishioka C. Phase II Study of the Reuse of Trastuzumab with Docetaxel beyond Progression after First-Line Treatment in Second-Line Treatment for Unresectable, Metastatic Gastric Cancer (T-CORE1203). Tohoku J Exp Med 254. 49-55. May (2021)
  4. Takahashi M，Sakamoto Y，Ohori H，Tsuji Y，Kuroki M，Kato S，Otsuka K，Komine K，Takahashi M，Takahashi S，Shirota H，Ouchi K，Takahashi Y，Imai H，Shibata H，Yoshioka T，Tanaka M，Yamaguchi H，Yamaguchi T，Shimodaira H，Ishioka C. Phase II study of trifluridine/tipiracil (TAS-102) therapy in elderly patients with colorectal cancer (T-CORE1401): geriatric assessment tools and plasma drug concentrations as possible predictive biomarkers. Cancer Chemotherapy and Pharmacology May 24 (2021)
  5. Hiratsuka Y，Oishi T，Miyashita M，Morita T，Mack J W，Sato Y，Takahashi M，Komine K，Saijo K，Ishioka C，Inoue A. Factors related to specialized palliative care use and aggressive care at end of life in Japanese patients with advanced solid cancers: a cohort study. Support Care Cancer Jun 25 (2021)
  6. Hishinuma E，Shimada M，Matsukawa N，Saigusa D，Li B，Kudo K，Tsuji K，Shigeta S，Tokunaga H，Kumada K，Komine K，Shirota H，Aoki Y，Motoike I N，Yasuda J，Kinoshita K，Yamamoto M，Koshiba S，Yaegashi N. Wide-Targeted Metabolome Analysis Identifies Potential Biomarkers for Prognosis Prediction of Epithelial Ovarian Cancer. Toxins (Basel) 13. Jun 30 (2021)
  7. Kawamura Y，Saijo K，Imai H，Ishioka C. Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid cancer cells. Cancer Science Jul 30 (2021)
  8. Denda T，Takashima A，Gamoh M，Iwanaga I，Komatsu Y，Takahashi M，Nakamura M，Ohori H，Sakashita A，Tsuda M，Kobayashi Y，Baba H，Kotake M，Ishioka C，Yamada Y，Sato A，Yuki S，Morita S，Takahashi S，Yamaguchi T，Shimada K. Combination therapy of bevacizumab with either S-1 and irinotecan or mFOLFOX6/CapeOX as first-line treatment of metastatic colorectal cancer (TRICOLORE): Exploratory analysis of RAS status and primary tumour location in a randomised, open-label, phase III, non-inferiority trial. European Journal of Cancer 154. 296-306. Sep (2021)
  9. Hiraide S，Takahashi M，Yoshida Y，Yamada H，Komine K，Ishioka C. Tumor suppressor miR-193a-3p enhances efficacy of BRAF/MEK inhibitors in BRAF-mutated colorectal cancer. Cancer Science 112. 3856-3870. Sep (2021)
  10. Ishii R，Ogawa T，Ohkoshi A，Nakanome A，Takahashi M，Katori Y. Use of the Geriatric-8 screening tool to predict prognosis and complications in older adults with head and neck cancer: A prospective, observational study. J Geriatr Oncol 12. 1039-1043. Sep (2021)
  11. Sunami K，Bando H，Yatabe Y，Naito Y，Takahashi H，Tsuchihara K，Toyooka S，Mimori K，Kohsaka S，Uetake H，Kinoshita I，Komine K，Takeda M，Hayashida T，Tamura K，Nishio K，Yamamoto N，Medicine T W G o a J T F o T A S f t P o C G. Appropriate use of cancer comprehensive genome profiling assay using circulating tumor DNA. Cancer Science 112. 3911-3917. Sep (2021)
  12. Yamada H，Takahashi M，Watanuki M，Watanabe M，Hiraide S，Saijo K，Komine K，Ishioka C. Erratum: lncRNA HAR1B has potential to be a predictive marker for pazopanib therapy in patients with sarcoma. Oncology Letters 22. 698. Oct (2021)
  13. Takahashi S，Fukui T，Nomizu T，Kakugawa Y，Fujishima F，Ishida T，Ohuchi N，Ishioka C. TP53 signature diagnostic system using multiplex reverse transcription-polymerase chain reaction system enables prediction of prognosis of breast cancer patients. Breast Cancer 28. 1225-1234. Nov (2021)
  14. Arai M，Ohno I，Takahashi K，Fan M M，Tawada A，Ishioka C，Takiguchi Y. Current status of medical oncology in Japan and changes over the most recent 7-year period: results of a questionnaire sent to designated cancer care hospitals. Jpn J Clin Oncol 51. 1622-1627. Nov 1 (2021)
  15. Tanizaki J，Yonemori K，Akiyoshi K，Minami H，Ueda H，Takiguchi Y，Miura Y，Segawa Y，Takahashi S，Iwamoto Y，Kidera Y，Fukuoka K，Ito A，Chiba Y，Sakai K，Nishio K，Nakagawa K，Hayashi H. Open-label phase II study of the efficacy of nivolumab for cancer of unknown primary. Ann Oncol 33. 216-226. Feb (2022)
  16. Yoshida S，Sato F，Tagami K，Takahashi S. Clinical Trial Protocol: Randomized Controlled Trial of Cancer Pain Monitoring System (CAPAMOS) in Patients with Advanced Cancer. Scientific Research Publishing 12. 113-124. Feb 21 (2022)
  17. Shimizu D，Takahashi M，Mizutani T. Interpretation of the Efficacy of Multidisciplinary Geriatric Assessment Intervention on Chemotherapy-Related Toxic Effects in Older Adults With Cancer. JAMA Oncol Feb 24 (2022)
  18. Ouchi K，Takahashi S，Okita A，Sakamoto Y，Muto O，Amagai K，Okada T，Ohori H，Shinozaki E，Ishioka C. A modified MethyLight assay predicts the clinical outcomes of anti-epidermal growth factor receptor treatment in metastatic colorectal cancer. Cancer Sci 113. 1057-1068. Mar (2022)
  19. Okada M，Kato K，Cho B C，Takahashi M，Lin C-Y，Chin K，Kadowaki S，Ahn M-J，Hamamoto Y，Doki Y，Yen C-C，Kubota Y，Kim S-B，Hsu C-H，Holtved E，Xynos I，Matsumura Y，Takazawa A，Kitagawa Y. Three-year follow-up and response-survival relationship of nivolumab in previously treated patients with advanced esophageal squamous cell carcinoma (ATTRACTION-3). Clin Cancer Res Mar 16 (2022)
  20. Mori T，Ueno K，Tokunaga K，Kawai Y，Matsuda K，Nishida N，Komine K，Saito S，Nagasaki M. A single-nucleotide-polymorphism in the 5'-flanking region of MSX1 gene as a predictive marker candidate for platinum-based therapy of esophageal carcinoma. Ther Adv Med Oncol 14. 17588359221080580. March (2022)
  21. Imai H，Saijo K，Komine K，Ueta R，Numakura R，Wakayama S，Umegaki S，Hiraide S，Kawamura Y，Kasahara Y，Ohuchi K，Takahashi M，Takahashi S，Shirota H，Takahashi M，Ishioka C. Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study. Cancer Manag Res 14. 1259-1266. March 25 (2022)

ページの先頭へ戻る

© 2006 Department of Medical Oncology, Tohoku University Hospital All rights reserved.